Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cincor Pharma, Inc. (CINC) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cincor Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1868734.
Total stock buying since 2022: $130,789,190.
Total stock sales since 2022: $86,011.
Total stock option exercises since 2022: $399,989.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 6,579,783 | $130,789,190 | 6,006 | $86,011 | 29,411 | $399,989 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-11 | 0 | $0 | 6,000 | $85,920 | 0 | $0 |
| 2022-08 | 1,822,333 | $54,669,990 | 0 | $0 | 29,411 | $399,989 |
| 2022-06 | 0 | $0 | 6 | $91 | 0 | $0 |
| 2022-01 | 4,757,450 | $76,119,200 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-11-28 | Sofinnova Venture Partners X, L.p. (10% Owner) | Sale | 6,000 | 14.32 | 85,920 |
| 2022-08-15 | Sofinnova Capital Ix (10% Owner) | Buy | 133,333 | 30.00 | 3,999,990 |
| 2022-08-15 | 5am Opportunities Ii, L.p. (10% Owner) | Buy | 600,000 | 30.00 | 18,000,000 |
| 2022-08-11 | General Atlantic (spv) Gp, Llc | Buy | 83,000 | 30.00 | 2,490,000 |
| 2022-08-11 | Katabi Maha | Buy | 500,000 | 30.00 | 15,000,000 |
| 2022-08-11 | Healy James | Buy | 506,000 | 30.00 | 15,180,000 |
| 2022-08-05 | Healy James (Director) | Option Ex | 29,411 | 13.60 | 399,989 |
| 2022-06-10 | Freeman Mason (Chief Medical Officer) | Sale | 6 | 15.21 | 91 |
| 2022-01-11 | De Garidel Marc (Chief Executive Officer) | Buy | 12,500 | 16.00 | 200,000 |
| 2022-01-11 | Pearce Catherine (Chief Operating Officer) | Buy | 2,250 | 16.00 | 36,000 |
| 2022-01-11 | General Atlantic Genpar (lux) Scsp | Buy | 1,700,000 | 16.00 | 27,200,000 |
| 2022-01-11 | Sofinnova Capital Ix (10% Owner) | Buy | 220,000 | 16.00 | 3,520,000 |
| 2022-01-11 | General Atlantic (spv) Gp, Llc | Buy | 1,700,000 | 16.00 | 27,200,000 |
| 2022-01-11 | Freeman Mason (EVP Clinical Development) | Buy | 2,600 | 16.00 | 41,600 |
| 2022-01-11 | Coelho Mary Theresa (EVP CFO & Chief BD Officer) | Buy | 100 | 16.00 | 1,600 |
| 2022-01-11 | Katabi Maha (10% Owner) | Buy | 325,000 | 16.00 | 5,200,000 |
| 2022-01-11 | Parmar Kush (10% Owner) | Buy | 470,000 | 16.00 | 7,520,000 |
| 2022-01-11 | Healy James (Director) | Buy | 325,000 | 16.00 | 5,200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CINC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cincor Pharma, Inc. (symbol CINC, CIK number 1868734) see the Securities and Exchange Commission (SEC) website.